Combination Therapy of Angiotensin Converting Enzyme Inhibitor and Angiotensin AT1 Receptor Antagonist in Diabetic Nephropathy

Tomoyuki Saito; Takako Saito; Hiroyuki Tamemoto; Miho Yuzawa; Masami Sasaki; Aki Ikoma; Masanobu Kawakami; San-e Ishikawa

首页> 外文期刊>Hong Kong Journal of Nephrology >Combination Therapy of Angiotensin Converting Enzyme Inhibitor and Angiotensin AT1 Receptor Antagonist in Diabetic Nephropathy

【24h】

Combination Therapy of Angiotensin Converting Enzyme Inhibitor and Angiotensin AT1 Receptor Antagonist in Diabetic Nephropathy

机译：糖尿病肾病中血管紧张素转换酶抑制剂和血管紧张素AT1受体拮抗剂的联合治疗

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hong Kong Journal of Nephrology》 |2007年第1期|共5页
作者
Tomoyuki Saito; Takako Saito; Hiroyuki Tamemoto; Miho Yuzawa; Masami Sasaki; Aki Ikoma; Masanobu Kawakami; San-e Ishikawa;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肾疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy [J] . Akihiko Nakamura, Daisuke Ogawa, Kenichi Shikata, Journal of diabetes investigation. . 2013,第2期

机译：血管紧张素转换酶抑制剂和血管紧张素II受体拮抗剂的联合治疗可改善糖尿病肾病患者的微炎症和氧化应激
2. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy. [J] . Kuriyama S, Tomonari H, Abe A, Nephron . 2000,第4期

机译：血管紧张素II受体拮抗剂和血管紧张素转化酶抑制剂联合治疗对1型糖尿病肾病患者明显蛋白尿的有益作用。
3. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy. [J] . Sato A, Tabata M, Hayashi K, Clinical and experimental nephrology . 2003,第3期

机译：与血管紧张素转换酶抑制剂相比，血管紧张素II 1型受体拮抗剂坎地沙坦对糖尿病肾病患者尿蛋白和尿蛋白排泄的影响。
4. Synthesis of the first highly potent inhibitor of the three vasopeptidases:endothelin converting enzyme (ECE),angiotensin converting enzyme (ACE) and neprilysin (NEP) [C] . Nicolas Inguimbert, Herve Poras, Pascale Coric, European Peptide Symposium . 2002

机译：三种血管肽酶的第一高效抑制剂的合成：内皮素转化酶（ECE），血管紧张素转化酶（ACE）和Neplysin（NEP）
5. Utilization of Vasopressin as a First Line Response to Perioperative Hypotension in the Patient on Angiotensin Receptor Antagonists and Angiotensin Converting Enzyme Inhibitors [D] . Buckley, Emily A. 2015

机译：利用血管加压素作为对围手术期低血压患者的血管紧张素受体拮抗剂和血管紧张素转化酶抑制剂的一线反应
6. Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy [O] . Akihiko Nakamura, Kenichi Shikata, Tatsuaki Nakatou, 2013

机译：血管紧张素转换酶抑制剂和血管紧张素II受体拮抗剂的联合治疗可改善糖尿病肾病患者的微炎症和氧化应激
7. Combination Therapy of Angiotensin Converting Enzyme Inhibitor and Angiotensin AT1 Receptor Antagonist in Diabetic Nephropathy [O] . Saito Tomoyuki, Saito Takako, Tamemoto Hiroyuki, 2007

机译：糖尿病肾病中血管紧张素转换酶抑制剂和血管紧张素AT1受体拮抗剂的联合治疗
8. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEls) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension. Comparative Effectiveness Review, Number 10 [R] . Matchar, D. B., McCrory, D. C., Orlando, L. A., 2007

机译：血管紧张素转换酶抑制剂（aCEls）和血管紧张素II受体拮抗剂（aRBs）治疗原发性高血压的疗效比较。比较效力评估，第10号

Combination Therapy of Angiotensin Converting Enzyme Inhibitor and Angiotensin AT1 Receptor Antagonist in Diabetic Nephropathy

著录项

相似文献

相关主题

期刊订阅